Hypercalcemia (High Calcium): Symptoms, Causes, and Risks

Symptom Deep-Dive Pages

Table of Contents

1. Symptom Deep-Dive Pages
2. Hypercalcemia Explained
3. Why High Calcium Is Dangerous
4. Why It Often Has No Symptoms
5. Common Causes of High Calcium
6. How Hypercalcemia Is Diagnosed
7. How High Calcium Is Treated
8. Red Flags and Emergency Signs
9. Key Research Papers
10. Connections
11. Featured Videos

Hypercalcemia Explained

Calcium is far more than a bone mineral. The roughly 1% of your body's calcium that circulates in the blood is tightly controlled because it helps run nerves, muscles (including the heart), hormone release, and blood clotting. Your body holds that blood level inside a narrow window using three tools working in concert: the bones (a vast calcium reservoir), the kidneys (which excrete or hold calcium), and the gut (which absorbs it from food) — all orchestrated mainly by parathyroid hormone (PTH) and vitamin D. Hypercalcemia is the medical word for a blood (serum) calcium level that is too high — most often defined as a value above about 10.5 mg/dL (2.6 mmol/L), just above the typical normal range of roughly 8.5 to 10.5 mg/dL (2.1–2.6 mmol/L). (Exact cut-offs vary slightly between laboratories.)

One technical point matters for understanding your own results. About half of the calcium in blood is bound to a protein called albumin; only the unbound, "free" (ionized) calcium is biologically active. If albumin is low — common in illness — the total calcium can read low even when the active calcium is normal, so clinicians either "correct" the calcium for the albumin level or measure ionized calcium directly. This is why a single total-calcium number is always interpreted in context.

How high the level climbs matters a great deal, because the danger scales with it. Clinicians generally think in three bands:

• Mild (about 10.5–12 mg/dL) — Usually silent. There are often no symptoms, and the value turns up on a routine blood test. The job here is to find out why — most commonly mild overactivity of the parathyroid glands — and to monitor, rather than to treat urgently.
• Moderate (about 12–14 mg/dL) — Symptoms such as excessive thirst and urination, constipation, nausea, fatigue, or low mood become more likely, though some people still feel well. How a person feels depends heavily on how quickly the level rose.
• Severe (above ~14 mg/dL), sometimes called hypercalcemic crisis — A medical emergency. Marked dehydration, vomiting, profound weakness, confusion, drowsiness progressing toward stupor, abnormal heart rhythms, and eventually coma can occur. This range is treated immediately, usually in a hospital.

Two facts are worth holding together. First, the most counter-intuitive truth about hypercalcemia is that mild cases are frequently asymptomatic — the level can be high while the person feels normal, which is exactly why it is so often a blood-test finding rather than a feeling. Second, symptoms track not just the number but the speed of the rise: a calcium that climbs quickly (as in some cancers) can make a person very ill at a level that someone with slow, long-standing parathyroid disease tolerates with few complaints. Doctors therefore weigh the level, the rate of rise, and the cause together.

Back to Table of Contents

Why High Calcium Is Dangerous

If mild hypercalcemia so often causes no symptoms, why is it taken seriously? Because calcium is a master signaling mineral, an elevated level disturbs several organ systems at once, and because high calcium is almost always a marker of an underlying disease that itself needs attention. The harm falls into a few clear categories.

• The kidneys — the organ most consistently affected. Excess calcium overwhelms the kidney's normal handling. It blunts the kidney's response to the water-conserving hormone, antidiuretic hormone (ADH, also called vasopressin), so the kidneys lose the ability to concentrate urine. The result is a vicious circle: large volumes of dilute urine (polyuria) cause dehydration and thirst, and dehydration in turn raises the blood calcium further, deepening the problem. Over the long term, persistent high calcium can deposit in the kidney tissue (nephrocalcinosis) and spill into the urine to form kidney stones — the "stones" of the classic mnemonic. The deep dive lives on the Kidney Stones and Thirst & Bone Pain pages.
• The digestive tract. Calcium calms (slows) smooth muscle, so high levels slow the gut: constipation, nausea, vomiting, and loss of appetite. Severe hypercalcemia can even inflame the pancreas (pancreatitis). See Constipation & Digestive.
• The brain and nervous system. Calcium influences how nerves fire, and a high level tends to dampen them. This produces the "moans": fatigue, difficulty concentrating, low mood or irritability, and — as levels climb — confusion, drowsiness, and ultimately stupor or coma. See Fatigue & Confusion.
• The heart. Because calcium is central to the heart's electrical cycle, severe hypercalcemia can change the electrocardiogram (a shortened QT interval is the classic finding) and, at extreme levels, provoke dangerous rhythm disturbances. This is uncommon but is part of why severe high calcium is an emergency.
• The bones. When the cause is an overactive parathyroid gland, the very hormone driving up the blood calcium is pulling it out of the bones, weakening them over years and raising the risk of osteoporosis and fractures. So the same process can show up as both high blood calcium and thinning bones at once (see Osteoporosis).

Holding these together explains the old teaching phrase "bones, stones, groans, and moans" (sometimes "abdominal groans and psychic moans"): bone pain, kidney stones, abdominal/digestive upset, and mood or cognitive changes. It is a useful memory aid — but, as the next section stresses, the absence of these complaints does not mean the calcium is fine.

Back to Table of Contents

Why It Often Has No Symptoms

One of the most important things to understand about high calcium is also one of the most surprising: much of the time, mild hypercalcemia does not feel like anything. This is especially true of its single most common cause — mild primary hyperparathyroidism — which today is usually picked up purely because calcium happens to be on a routine blood panel. A person can have an elevated calcium for years and feel entirely well, or have only subtle complaints (a little more fatigue, a bit more constipation, a touch of brain fog) that are easy to attribute to ordinary life, ageing, or stress.

Why is it so quiet? Largely because the body adapts when the rise is slow. The classic "bones, stones, groans, and moans" picture was described in an era when hypercalcemia was usually diagnosed late, at higher levels, after symptoms had developed. Now that calcium is measured routinely, most cases are caught early and mildly — and at that stage the symptoms are minimal or absent. The flip side is that when calcium rises quickly (as it can with a cancer), even a moderately high level can make someone acutely and obviously ill. So the same number can be silent in one person and alarming in another, depending on how fast it arrived.

This is why diagnosis rests on the blood test, not on how you feel. Several groups are worth flagging, because in them an unexpected or mildly high calcium carries extra weight:

• Anyone in whom calcium is found high on routine bloodwork — even if they feel completely well. Mild primary hyperparathyroidism is, by far, the leading explanation in an otherwise healthy outpatient.
• People with a known or suspected cancer, in whom a rising calcium can be the first sign that something needs attention; hypercalcemia of malignancy tends to develop faster and reach higher levels.
• People taking calcium plus vitamin D supplements, certain other medicines (such as thiazide diuretics or lithium), or large amounts of antacids — situations where the cause may be partly self-administered.
• Anyone with unexplained kidney stones, osteoporosis, or peptic ulcers/pancreatitis, since long-standing high calcium can sit silently behind all of these.

The take-home message is the opposite of reassuring silence: feeling fine does not prove your calcium is fine. A high level on a blood test remains a finding to be confirmed and explained, because the absence of symptoms does not rule out a cause.

Back to Table of Contents

Common Causes of High Calcium

An old clinical saying captures the reality well: in the outpatient clinic, high calcium is hyperparathyroidism until proven otherwise; in the hospital, it is cancer until proven otherwise. Together, those two causes account for the great majority of cases. Here are the causes worth knowing.

• Primary hyperparathyroidism — the number-one cause overall. The four tiny parathyroid glands in the neck sense blood calcium and release parathyroid hormone (PTH) to raise it. In primary hyperparathyroidism, one (occasionally more) of these glands becomes overactive — usually from a benign tumor called an adenoma — and pumps out too much parathyroid hormone regardless of the calcium level. Parathyroid hormone then pulls calcium out of bone, tells the kidney to retain calcium, and boosts vitamin D activation to absorb more from food. The result is a chronically high calcium, very often mild and silent, found on routine testing. It is the leading cause in healthy outpatients. See Hyperparathyroidism.
• Cancer (hypercalcemia of malignancy) — the leading cause in sick, hospitalized people. Several cancers raise calcium, and they tend to do it faster and to higher, more symptomatic levels than hyperparathyroidism. The commonest mechanism is a tumor releasing a hormone-like protein, parathyroid hormone-related protein (PTHrP), that mimics parathyroid hormone (seen in lung, breast, kidney, and some other cancers). Other tumors raise calcium by spreading to bone and dissolving it, or — in some lymphomas — by overproducing active vitamin D. Hypercalcemia of malignancy is generally a sign of advanced disease and an important problem in its own right.
• Vitamin D excess. Too much active vitamin D drives the gut to absorb more calcium. This can come from very high-dose vitamin D supplements (true toxicity is rare but real), or from granulomatous diseases such as sarcoidosis and some infections (e.g. tuberculosis), in which immune cells convert vitamin D to its active form unchecked. See Vitamin D3.
• Medications. Several drugs raise calcium: thiazide diuretics (common blood-pressure "water pills" that make the kidney hold on to calcium), lithium (used for bipolar disorder, which can disturb the parathyroid glands' calcium-sensing over time), and high-dose vitamin A derivatives. Excess calcium supplements — especially calcium carbonate antacids taken in large amounts — can do it too, sometimes via the calcium-alkali (milk-alkali) syndrome described below.
• Calcium-alkali (milk-alkali) syndrome. Originally described in people taking milk and antacids for ulcers, this syndrome has re-emerged in the era of over-the-counter calcium-carbonate supplements taken for bone health or as heartburn remedies. Large intakes of calcium plus absorbable alkali (carbonate) produce a triad of high calcium, metabolic alkalosis, and kidney impairment. A 2010 review calls it the third most common cause of hospital admission for hypercalcemia, with postmenopausal or pregnant women at greatest risk, and says its incidence is growing largely because of the widespread use of over-the-counter calcium and vitamin D supplements (Patel and Goldfarb 2010).
• Prolonged immobilization. Bone is constantly remodeled, and weight-bearing activity restrains the cells that break it down. Long periods of complete immobility (for example, extended bed rest after a major injury, particularly in younger people with rapid bone turnover) can release enough calcium from unloaded bone to raise the blood level.
• Other endocrine and rare causes. Overactive thyroid (hyperthyroidism), adrenal insufficiency, and rare inherited conditions such as familial hypocalciuric hypercalcemia (a usually benign genetic difference in calcium sensing that is easily mistaken for hyperparathyroidism but is not a condition treated with surgery) round out the list.

A practical note: as with many electrolyte problems, more than one factor can stack up. Someone with mild primary hyperparathyroidism who also takes a thiazide diuretic, high-dose vitamin D, and calcium-carbonate antacids may tip from a borderline level into a clearly high one from the sum of several modest contributions.

Back to Table of Contents

How Hypercalcemia Is Diagnosed

Because mild hypercalcemia is usually silent, it is almost always discovered the same way: on a blood test. A basic metabolic panel (BMP) or a comprehensive metabolic panel (CMP) — routine, inexpensive, and frequently ordered — reports serum calcium directly. Many people first learn their calcium is high not from a symptom but from bloodwork drawn for a check-up or to monitor something else entirely. (For what the panel measures and how to read it, see the Comprehensive Metabolic Panel page.)

When a high value comes back, the first steps are to make sure it is real and to interpret it correctly. The total calcium is checked against the albumin level (or an ionized calcium is measured) so that a result is not misread because of an abnormal protein level. A genuinely high value is then usually repeated to confirm it before any larger work-up — a falsely high reading from a tight tourniquet or a delayed sample is not the same as true hypercalcemia.

Once the high calcium is confirmed, the central question becomes why. Here the single most useful test is straightforward:

• Parathyroid hormone (PTH). This one test splits the diagnosis cleanly. If calcium is high and parathyroid hormone is also high (or inappropriately normal), the parathyroid glands are the problem — primary hyperparathyroidism. If calcium is high but parathyroid hormone is appropriately low (suppressed, as it should be when calcium is high), the cause lies elsewhere — most importantly cancer, vitamin D excess, or one of the other causes above. This branch point guides everything that follows.
• When parathyroid hormone is suppressed, the search turns to a hidden cause: tests may include parathyroid hormone-related protein (PTHrP) and a hunt for cancer, vitamin D levels (both forms), and screening for granulomatous disease such as sarcoidosis.
• Kidney function and a urine calcium — the metabolic panel reports creatinine (kidney function), and a 24-hour urine calcium helps distinguish primary hyperparathyroidism from the benign inherited condition (familial hypocalciuric hypercalcemia), which is important because the two are treated completely differently.
• A careful medication and supplement review — the doctor will ask specifically about calcium and vitamin D supplements, antacids, thiazide diuretics, lithium, and vitamin A, since these are common and reversible contributors.
• An electrocardiogram (ECG) — mainly when the level is high or the person is symptomatic, to check for the shortened QT interval and other changes that signal the heart is being affected.

This orderly approach — confirm the value, correct for albumin, then check parathyroid hormone — is what turns a single high number into an actual diagnosis and the right treatment.

Back to Table of Contents

How High Calcium Is Treated

Treatment depends on how high the calcium is, how fast it rose, whether there are symptoms, and above all why it is happening — because correcting the underlying cause is the real cure. No home method lowers a high calcium safely. For the supplement-driven calcium-alkali syndrome, a 2010 review lists the best treatment as restoring blood volume, increasing kidney filtration and calcium excretion, and stopping calcium supplements (Patel and Goldfarb 2010). The approach divides naturally into managing a high level acutely and treating the root cause.

Acute treatment of moderate-to-severe hypercalcemia follows a logical sequence aimed at diluting the calcium, helping the body excrete it, and switching off its release from bone:

• Rehydration with intravenous fluids — the cornerstone. People with significant hypercalcemia are almost always dehydrated (because high calcium makes them urinate excessively). Generous intravenous (IV) saline both dilutes the blood calcium and restores kidney blood flow so the kidneys can excrete calcium again. This alone often brings the level down meaningfully and is the first move in nearly every case.
• Bisphosphonates — to switch off bone release. Much of the excess calcium, especially in cancer, comes from bone being dissolved. Intravenous bisphosphonates (such as zoledronic acid or pamidronate) shut down the bone-resorbing cells. They work over a day or two rather than minutes, so they are given alongside fluids and provide more durable control. Zoledronic acid has been shown in trials to be more effective than older pamidronate for hypercalcemia of malignancy.
• Calcitonin — for fast but short-lived help. This hormone lowers calcium quickly (within hours) but its effect fades after a couple of days, so it is used as a bridge while slower agents take hold.
• Denosumab — now a first-choice option for cancer-related high calcium. This injected antibody also blocks bone breakdown. The 2023 Endocrine Society guideline strongly recommends either denosumab or an intravenous bisphosphonate for adults with hypercalcemia of malignancy, suggests denosumab rather than an intravenous bisphosphonate (a conditional recommendation based on low-certainty evidence), and suggests denosumab when high calcium persists or returns despite bisphosphonate treatment. It is also an option when poor kidney function makes bisphosphonates unsuitable.
• Glucocorticoids (steroids) — specifically useful when the cause is vitamin D excess, granulomatous disease (sarcoidosis), or certain lymphomas, because they reduce the over-activation of vitamin D.
• Dialysis — reserved for severe, life-threatening hypercalcemia, especially when the kidneys are failing or the heart is at risk.

The same 2023 Endocrine Society guideline on hypercalcemia of malignancy also suggests calcitonin together with an intravenous bisphosphonate or denosumab as the opening treatment in severe cases; adding an intravenous bisphosphonate or denosumab for tumors that make large amounts of active vitamin D (calcitriol) when calcium stays severe or symptomatic despite steroids; and either a calcimimetic (the drug class that includes cinacalcet) or a bone-acting drug for high calcium caused by parathyroid cancer. It states that treating the cancer itself is what controls the high calcium and keeps it from returning (El-Hajj Fuleihan 2023).

Treating the underlying cause is what ultimately resolves the problem:

• Primary hyperparathyroidism — the definitive treatment is surgery to remove the overactive gland (parathyroidectomy), which is highly effective and often cures the condition. Mild, asymptomatic cases that do not meet surgical criteria may instead be monitored over time, with attention to calcium, kidney function, and bone density; a calcium-lowering medicine (cinacalcet) is an option for some who cannot have surgery. The criteria for choosing surgery versus monitoring are set out in the 2022 guidelines of the Fifth International Workshop on primary hyperparathyroidism, written by more than 50 experts using formal evidence-grading methods (GRADE); they replaced the 2014 workshop guidelines and revised the kidney criteria (Bilezikian 2022). See Hyperparathyroidism.
• Cancer — lowering the calcium is supportive care; controlling the cancer itself (with its own treatment) is what addresses the source.
• Medication- or supplement-driven cases — often resolve simply by stopping the offending agent: the thiazide diuretic, lithium, high-dose vitamin D, or excess calcium-carbonate antacids (as in calcium-alkali syndrome).

The reassuring part is that, identified in time, hypercalcemia is very treatable — and in the common case of primary hyperparathyroidism, often curable. The whole point of evaluating a high calcium promptly is to find and fix the cause before it damages the kidneys or bones.

Back to Table of Contents

Red Flags and Emergency Signs

Because mild high calcium is usually silent, the most important "red flag" is often the blood result itself: a routine test showing a calcium above the normal range is itself the warning, even in a person who feels perfectly well — having no symptoms does not mean there is no problem. Certain symptoms suggest the calcium may be dangerously high. Hospitals treat the following as emergency signs, especially when they occur together:

• Confusion, marked drowsiness, or difficulty staying awake — changes in alertness or thinking can signal severe hypercalcemia affecting the brain.
• Persistent vomiting with signs of dehydration — especially when combined with intense thirst and heavy urination, which feed a dangerous cycle.
• Severe weakness — profound muscle weakness or being unable to function normally.
• A fast, slow, or irregular heartbeat, fainting, or chest discomfort — possible signs the heart's rhythm is affected.
• Severe abdominal pain — which can reflect a complication such as pancreatitis.

A high or borderline calcium carries more weight, though it is not usually an emergency, in people with unexplained kidney stones, osteoporosis, persistent constipation or excessive thirst and urination, and in people who take calcium and vitamin D supplements (or antacids, thiazide diuretics, or lithium). Supplement- and medicine-driven cases often resolve once the agent is stopped, dehydration pushes calcium higher, and a repeat test confirms whether the level is truly high. For overlapping symptoms, see Fatigue, Brain Fog, Constipation, and Nausea & Vomiting.

Back to Table of Contents

Key Research Papers

1. Minisola S, Pepe J, Piemonte S, et al. (2015). The diagnosis and management of hypercalcaemia. BMJ;350:h2723. — DOI: 10.1136/bmj.h2723. — doi:10.1136/bmj.h2723
2. Stewart AF (2005). Hypercalcemia Associated with Cancer. New England Journal of Medicine;352(4):373-379. — DOI: 10.1056/NEJMcp042806. — doi:10.1056/NEJMcp042806
3. Marcocci C, Cetani F (2011). Primary Hyperparathyroidism. New England Journal of Medicine;365(25):2389-2397. — DOI: 10.1056/NEJMcp1106636. — doi:10.1056/NEJMcp1106636
4. Bilezikian JP, Brandi ML, Eastell R, et al. (2014). Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. The Journal of Clinical Endocrinology & Metabolism;99(10):3561-3569. — DOI: 10.1210/jc.2014-1413. — doi:10.1210/jc.2014-1413
5. Bilezikian JP, Khan AA, Silverberg SJ, et al. (2022). Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research;37(11):2293-2314. — DOI: 10.1002/jbmr.4677. — doi:10.1002/jbmr.4677
6. Mirrakhimov AE (2015). Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. North American Journal of Medical Sciences;7(11):483-493. — DOI: 10.4103/1947-2714.170600. — doi:10.4103/1947-2714.170600
7. Major P, Lortholary A, Hon J, et al. (2001). Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials. Journal of Clinical Oncology;19(2):558-567. — DOI: 10.1200/JCO.2001.19.2.558. — doi:10.1200/JCO.2001.19.2.558
8. Hu MI, Glezerman IG, Leboulleux S, et al. (2014). Denosumab for Treatment of Hypercalcemia of Malignancy. The Journal of Clinical Endocrinology & Metabolism;99(9):3144-3152. — DOI: 10.1210/jc.2014-1001. — doi:10.1210/jc.2014-1001
9. El-Hajj Fuleihan G, Clines GA, Hu MI, et al. (2023). Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism;108(3):507-528. — DOI: 10.1210/clinem/dgac621. — doi:10.1210/clinem/dgac621
10. Patel AM, Goldfarb S (2010). Got Calcium? Welcome to the Calcium-Alkali Syndrome. Journal of the American Society of Nephrology;21(9):1440-1443. — DOI: 10.1681/ASN.2010030255. — doi:10.1681/ASN.2010030255
11. Curhan GC, Willett WC, Rimm EB, et al. (1993). A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones. New England Journal of Medicine;328(12):833-838. — DOI: 10.1056/NEJM199303253281203. — doi:10.1056/NEJM199303253281203
12. Curhan GC, Willett WC, Speizer FE, et al. (1997). Comparison of Dietary Calcium with Supplemental Calcium and Other Nutrients as Factors Affecting the Risk for Kidney Stones in Women. Annals of Internal Medicine;126(7):497-504. — DOI: 10.7326/0003-4819-126-7-199704010-00001. — doi:10.7326/0003-4819-126-7-199704010-00001
13. Bolland MJ, Grey A, Avenell A, et al. (2011). Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ;342:d2040. — DOI: 10.1136/bmj.d2040. — doi:10.1136/bmj.d2040
14. Sadiq NM, Naganathan S, Badireddy M (2023). Hypercalcemia. StatPearls [Internet], Treasure Island (FL): StatPearls Publishing. — PubMed

PubMed Topic Searches

1. PubMed: Hypercalcemia: causes, diagnosis, and management
2. PubMed: Primary hyperparathyroidism and hypercalcemia
3. PubMed: Hypercalcemia of malignancy (PTHrP, bisphosphonates)
4. PubMed: Calcium-alkali (milk-alkali) syndrome
5. PubMed: Vitamin D toxicity and hypercalcemia

Back to Table of Contents

Connections

• All Minerals
• Hypercalcemia: Kidney Stones
• Hypercalcemia: Constipation & Digestive
• Hypercalcemia: Fatigue & Confusion
• Hypercalcemia: Thirst & Bone Pain
• Calcium Overview
• Hypocalcemia (Low Calcium) Hub
• Calcium Benefits Hub
• Calcium and Bone Health
• Hyperparathyroidism
• Kidney Stones
• Osteoporosis
• Kidney Disease
• Comprehensive Metabolic Panel
• Vitamin D3
• Phosphorus
• Magnesium
• Baking Soda

Back to Table of Contents

×

Featured Videos